Stanford researchers have created a novel wearable device and system to assess fatigue on the user based on electrical activity associated with an eye blink of the subject.
Stanford researchers have developed a method for identifying the foveal center in the eye for high resolution retinal mapping in adaptive optics devices using artificial intelligence.
Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.
Researchers at Stanford have developed a porous biologics-loaded multimaterial construct, called Hybrid Tissue Engineering Construct (HyTEC), with applications in regenerative medicine and therapeutic delivery.
Based on their proprietary HyTEC tissue engineering platform, researchers at Stanford have developed an osteoinductive intramedullary implant (IM) device for improved bone healing.
Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.
Stanford researchers have developed a new method of imaging cholesteatoma, an expanding and destructive lesion of the middle ear and mastoid, based on its chemical composition.
Stanford scientists have invented a new PET-nanophotonic metamaterial scintillator that consists of tunable scintillating alkaline-earth rare-earth fluoride nanoparticles (MLnF) for low-dose, high-resolution PET imaging.
Researchers at Stanford have developed an innovation that will enhance the depth of the imaging capabilities for optical coherence tomography (OCT) imaging.
Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.
Knee osteoarthritis is the most common cause of musculoskeletal pain in adults, leading to limited mobility and various health issues. This breakthrough technology developed by Stanford researchers offers a promising solution.
Stanford researchers at the Snyder Lab have developed a novel software application, called the Metabolic Subphenotype Predictor, which predicts if a patient is insulin resistant through continuous glucose monitoring.
Stanford researchers have designed a remote digital health platform to assist diagnosis and management of some inflammatory skin conditions, such as eczema.
Stanford researchers at the Lee Lab have developed a new system and method for measuring pathology then applying a novel algorithm to optimize neurostimulation therapy for altering pathology for treatment of neurodegenerative diseases.